Life-Saving Collaboration: Aster CMI Hospital and Coal India Provide Bone Marrow Transplants

▴ ASTER DM HEALTHCARE
Children born with these rare, life-threatening conditions require ongoing medical support and medications to live normal lives like their peers and this noble partnership aims to cure as many patients as possible and extend the lifespan of these children.

 

Bengaluru, September 05, 2024, –Aster CMI Hospital and Coal India Ltd have partnered to provide life-saving bone marrow transplants for children with thalassaemia and aplastic anaemia conditions.  This initiative, supported by the Health Ministry of India, allows Coal India Ltd.’s Corporate Social Responsibility project to financially assist bone marrow transplant treatments for these life-threatening conditions. Aster CMI Hospital is empanelled for this project, enabling it to provide these critical treatments. 

As part of the understanding, Coal India has committed to providing upto Rs. 3 crores to treat thalassaemia and aplastic anaemia patients for a period of 3 years. This funding will enable us to provide medical assistance to approximately 300 patients."

Dr. Somashekhar S P, Lead Consultant - Surgical & Gynaecological Oncology & Robotic Surgeon, Aster CMI Hospital, Bangalore, stated, “Our Haematology-Oncology Department's expertise in complex surgeries and advanced treatments enables us to deliver exceptional care to these patients. This collaboration will significantly expand our reach and impact, enabling us to extend our treatment to a larger number of patients and it will mainly benefit economically weaker sections patients."

Dr. Stalin Ramprakash, Senior Consultant of Pediatric Hematology-Oncology and Bone Marrow Transplant, Aster CMI Hospital, Bangalore mentioned, “Thalassemia and aplastic anaemia are life-threatening conditions where the bone marrow fails. Without treatment, most patient’s lifespan will decrease drastically., in few instances for less than a year.  This tie-up will enable us to offer curative BMT treatment to many more children with these conditions so that they can lead a normal fulfilling life they deserve.”

 “We are honoured to collaborate with Coal India Limited on this life-saving initiative. We are certain with the support of our skilled doctors and advanced technologies available at the hospital, we will achieve the partnership’s objective. This collaboration aligns perfectly with Aster DM foundation, which focuses on improving the lives of underprivileged communities through healthcare outreach, education, and other social welfare programs, added Mr. SGS Lakshmanan, COO, Aster CMI Hospital, Bangalore.

Mr. Shri Vinay Ranjan, Director of Coal India Limited, said, “We believe that this partnership with Aster CMI Hospital will significantly enhance the quality of life for our employees and their families. By combining our resources and expertise, we can make a tangible difference in the lives of those in need.”

Children born with these rare, life-threatening conditions require ongoing medical support and medications to live normal lives like their peers and this noble partnership aims to cure as many patients as possible and extend the lifespan of these children.

About ASTER DM HEALTHCARE

Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in GCC and in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary, and quaternary healthcare through our 30 hospitals, 121 clinics, 459* pharmacies, 19 labs and 140 patient experience centres in seven countries, including India. We have over 28,400 plus dedicated staff including 3,622 doctors and 8,095 nurses across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands. * Including 214 Pharmacies in India operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026